retatrutide dosing trials for weight loss: Study shows 30% body weight loss retatrutide dosing schedule clinical trial

M.BurgessD

The combined 8mg groups lost 22.8%

At 24 weeks, liver-fat content (measured by non-invasive imaging, MRI-PDFF) fell by 81.4% on 8 mg and 82.4% on 12 mg, compared with a small increase in those participants on the placebo

Safety Concerns and Reported Complications There have been growing reports of adverse reactions associated with compounded semaglutide, including unexpected gastrointestinal side effects, excessive nausea, severe dehydration, and symptoms not typically seen with FDA-approved GLP-1 medications

But heres what nearly everyone discovers after the first couple of rounds: Its quicker, easier, and far less painful than you imagined

Sehgal NK et al